Literature DB >> 21292727

Assessment of follicular development in cryopreserved primate ovarian tissue by xenografting: prepubertal tissues are less sensitive to the choice of cryoprotectant.

V von Schönfeldt1, R Chandolia, L Kiesel, E Nieschlag, S Schlatt, B Sonntag.   

Abstract

Improvements in cancer survival rates have renewed interest in the cryopreservation of ovarian tissue for fertility preservation. We used the marmoset as a non-human primate model to assess the effect of different cryoprotectives on follicular viability of prepubertal compared to adult ovarian tissue following xenografting. Cryopreservation was performed with dimethylsulfoxide (DMSO), 1,2-propanediol (PrOH), or ethylene glycol (EG) using a slow freezing protocol. Subsequently, nude mice received eight grafts per animal from the DMSO and the PrOH groups for a 4-week grafting period. Fresh, cryopreserved-thawed, and xenografted tissues were serially sectioned and evaluated for the number and morphology of follicles. In adult tissue, the percentage of morphologically normal primordial follicles significantly decreased from 41.2 ± 4.5% (fresh) to 13.6 ± 1.8 (DMSO), 9.5 ± 1.7 (PrOH), or 6.8 ± 1.0 (EG) following cryopreservation. After xenografting, the percentage of morphologically normal primordial (26.2 ± 2.5%) and primary follicles (28.1 ± 5.4%) in the DMSO group was significantly higher than that in the PrOH group (12.2 ± 3 and 5.4 ± 2.1% respectively). Proliferating cell nuclear antigen (PCNA) staining suggests the resumption of proliferative activity in all cellular compartments. In prepubertal tissues, primordial but not primary follicles display a similar sensitivity to cryopreservation, and no significant differences between DMSO and PrOH following xenografting were observed. In conclusion, DMSO shows a superior protective effect on follicular morphology compared with PrOH and EG in cryopreserved tissues. Xenografting has confirmed better efficacy of DMSO versus PrOH in adult but not in prepubertal tissues, probably owing to a greater capacity of younger animals to compensate for cryoinjury.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21292727     DOI: 10.1530/REP-10-0454

Source DB:  PubMed          Journal:  Reproduction        ISSN: 1470-1626            Impact factor:   3.906


  4 in total

1.  Cryopreservation of ovaries from neonatal marmoset monkeys.

Authors:  Hideyuki H Motohashi; Hidetoshi Ishibashi
Journal:  Exp Anim       Date:  2016-02-15

2.  Clinically applied procedures for human ovarian tissue cryopreservation result in different levels of efficacy and efficiency.

Authors:  Lobke Bastings; Johan R Westphal; Catharina C M Beerendonk; Ruud L M Bekkers; Petra L M Zusterzeel; Jan C M Hendriks; Didi D M Braat; Ronald Peek
Journal:  J Assist Reprod Genet       Date:  2016-10-06       Impact factor: 3.412

3.  A new strategy and system for the ex vivo ovary perfusion and cryopreservation: An innovation.

Authors:  Mohamed Shehata Ali Mohamed
Journal:  Int J Reprod Biomed       Date:  2017-06

4.  FSH prevents depletion of the resting follicle pool by promoting follicular number and morphology in fresh and cryopreserved primate ovarian tissues following xenografting.

Authors:  Viktoria von Schönfeldt; Ramesh Chandolia; Robert Ochsenkühn; Eberhard Nieschlag; Ludwig Kiesel; Barbara Sonntag
Journal:  Reprod Biol Endocrinol       Date:  2012-11-24       Impact factor: 5.211

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.